Biomarker Type: Proteomic
-
First Look at the Distribution of Risk of Malignancy Pre and Post-Test Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study
-
Real World Performance of Blood Based Host Immune Profiling in First line Immunotherapy Treatment in Advanced Stage Non Small Cell Lung Cancer
-
Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach
-
Extending the information content of the MALDI analysis of biological fluids via multi-million shot analysis
-
Application of protein set enrichment analysis to correlation of protein functional sets with mass spectral features and multivariate proteomic tests
-
Mass Spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
-
The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy
-
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarkerstratified, randomised phase 3 trial
-
Utilizing a Nodule Classifier for Management of Incidental Nodules: A Case Report
-
Improving the Power of Gene Set Enrichment Analysis